GIKLY
Price
$7.14
Change
-$0.35 (-4.67%)
Updated
Sep 4 closing price
Capitalization
8.48B
39 days until earnings call
GLAXF
Price
$19.77
Change
-$0.43 (-2.13%)
Updated
Sep 26 closing price
Capitalization
79.76B
Interact to see
Advertisement

GIKLY vs GLAXF

Header iconGIKLY vs GLAXF Comparison
Open Charts GIKLY vs GLAXFBanner chart's image
Grifols Sa
Price$7.14
Change-$0.35 (-4.67%)
Volume$171
Capitalization8.48B
GSK
Price$19.77
Change-$0.43 (-2.13%)
Volume$346
Capitalization79.76B
GIKLY vs GLAXF Comparison Chart in %
Loading...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIKLY vs. GLAXF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIKLY is a Buy and GLAXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (GIKLY: $7.14 vs. GLAXF: $19.77)
Brand notoriety: GIKLY and GLAXF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIKLY: 136% vs. GLAXF: 6%
Market capitalization -- GIKLY: $8.48B vs. GLAXF: $79.76B
GIKLY [@Pharmaceuticals: Major] is valued at $8.48B. GLAXF’s [@Pharmaceuticals: Major] market capitalization is $79.76B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $649.52B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIKLY’s FA Score shows that 1 FA rating(s) are green whileGLAXF’s FA Score has 2 green FA rating(s).

  • GIKLY’s FA Score: 1 green, 4 red.
  • GLAXF’s FA Score: 2 green, 3 red.
According to our system of comparison, GLAXF is a better buy in the long-term than GIKLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIKLY’s TA Score shows that 4 TA indicator(s) are bullish while GLAXF’s TA Score has 5 bullish TA indicator(s).

  • GIKLY’s TA Score: 4 bullish, 3 bearish.
  • GLAXF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLAXF is a better buy in the short-term than GIKLY.

Price Growth

GIKLY (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while GLAXF (@Pharmaceuticals: Major) price change was +2.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.20%. For the same industry, the average monthly price growth was -0.44%, and the average quarterly price growth was +12.50%.

Reported Earning Dates

GIKLY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.20% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLAXF($79.8B) has a higher market cap than GIKLY($8.48B). GIKLY has higher P/E ratio than GLAXF: GIKLY (27.64) vs GLAXF (17.78). GIKLY YTD gains are higher at: 53.720 vs. GLAXF (17.533). GLAXF has higher annual earnings (EBITDA): 8.61B vs. GIKLY (1.62B). GLAXF has more cash in the bank: 3.62B vs. GIKLY (566M). GIKLY has less debt than GLAXF: GIKLY (8.82B) vs GLAXF (17.4B). GLAXF has higher revenues than GIKLY: GLAXF (31.6B) vs GIKLY (7.45B).
GIKLYGLAXFGIKLY / GLAXF
Capitalization8.48B79.8B11%
EBITDA1.62B8.61B19%
Gain YTD53.72017.533306%
P/E Ratio27.6417.78155%
Revenue7.45B31.6B24%
Total Cash566M3.62B16%
Total Debt8.82B17.4B51%
FUNDAMENTALS RATINGS
GIKLY vs GLAXF: Fundamental Ratings
GIKLY
GLAXF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8440
PRICE GROWTH RATING
1..100
4457
P/E GROWTH RATING
1..100
7920
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLAXF's Valuation (6) in the null industry is in the same range as GIKLY (28). This means that GLAXF’s stock grew similarly to GIKLY’s over the last 12 months.

GLAXF's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that GLAXF’s stock grew similarly to GIKLY’s over the last 12 months.

GLAXF's SMR Rating (40) in the null industry is somewhat better than the same rating for GIKLY (84). This means that GLAXF’s stock grew somewhat faster than GIKLY’s over the last 12 months.

GIKLY's Price Growth Rating (44) in the null industry is in the same range as GLAXF (57). This means that GIKLY’s stock grew similarly to GLAXF’s over the last 12 months.

GLAXF's P/E Growth Rating (20) in the null industry is somewhat better than the same rating for GIKLY (79). This means that GLAXF’s stock grew somewhat faster than GIKLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIKLYGLAXF
RSI
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
33%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
47%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
67%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
66%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
63%
Aroon
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VFVA127.801.37
+1.08%
Vanguard US Value Factor ETF
SPMD57.250.57
+1.01%
SPDR® Portfolio S&P 400™ Mid Cap ETF
FDAT22.290.13
+0.60%
Tactical Advantage ETF
BSJU26.120.03
+0.11%
Invesco BulletShares 2030 HY Corp Bd ETF
BTCI56.94N/A
N/A
NEOS Bitcoin High Income ETF

GIKLY and

Correlation & Price change

A.I.dvisor tells us that GIKLY and OPHLY have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIKLY and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIKLY
1D Price
Change %
GIKLY100%
N/A
OPHLY - GIKLY
10%
Poorly correlated
+1.60%
GLAXF - GIKLY
8%
Poorly correlated
-2.10%
NVSEF - GIKLY
7%
Poorly correlated
+0.25%
ORINY - GIKLY
4%
Poorly correlated
N/A
KYKOF - GIKLY
3%
Poorly correlated
N/A
More

GLAXF and

Correlation & Price change

A.I.dvisor tells us that GLAXF and OPHLY have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GLAXF and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
-2.10%
OPHLY - GLAXF
9%
Poorly correlated
+1.60%
GIKLY - GLAXF
8%
Poorly correlated
N/A
ORINY - GLAXF
3%
Poorly correlated
N/A
NVSEF - GLAXF
-0%
Poorly correlated
+0.25%
OPHLF - GLAXF
-2%
Poorly correlated
N/A
More